FMCQF - Outset Medical Begins U.S. IPO Rollout
Quick Take
Outset Medical (OM) has filed to raise $100 million in an IPO of its common stock, according to an S-1 registration statement.
The firm has developed a patented hemodialysis machine for patients with reduced kidney function.
OM looks well positioned to provide a differentiated and easier to use offering in both clinical and home settings.
I’ll provide a final opinion when we learn more about the IPO from management.
Company & Technology
San Jose, California-based Outset was founded to design improved hemodialysis technologies to reduce the infrastructure required to operate